These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3081661)

  • 21. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.
    Gosselin D; Stevenson MM; Cowley EA; Griesenbach U; Eidelman DH; Boulé M; Tam MF; Kent G; Skamene E; Tsui LC; Radzioch D
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1253-62. PubMed ID: 9563748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes.
    Alhede M; Bjarnsholt T; Jensen PØ; Phipps RK; Moser C; Christophersen L; Christensen LD; van Gennip M; Parsek M; Høiby N; Rasmussen TB; Givskov M
    Microbiology (Reading); 2009 Nov; 155(Pt 11):3500-3508. PubMed ID: 19643762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
    LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa.
    Larsen GL; Mitchell BC; Harper TB; Henson PM
    Am Rev Respir Dis; 1982 Aug; 126(2):306-11. PubMed ID: 7103255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
    Woods DE; Cantin A; Cooley J; Kenney DM; Remold-O'Donnell E
    Pediatr Pulmonol; 2005 Feb; 39(2):141-9. PubMed ID: 15633200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.
    Nieuwenhuis EE; Matsumoto T; Exley M; Schleipman RA; Glickman J; Bailey DT; Corazza N; Colgan SP; Onderdonk AB; Blumberg RS
    Nat Med; 2002 Jun; 8(6):588-93. PubMed ID: 12042809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
    Cantin AM; Woods DE
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1130-5. PubMed ID: 10508798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
    Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alveolar neutrophils in endotoxin-induced and bacteria-induced acute lung injury in rats.
    Delclaux C; Rezaiguia-Delclaux S; Delacourt C; Brun-Buisson C; Lafuma C; Harf A
    Am J Physiol; 1997 Jul; 273(1 Pt 1):L104-12. PubMed ID: 9252546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog.
    Ozaki T; Maeda M; Hayashi H; Nakamura Y; Moriguchi H; Kamei T; Yasuoka S; Ogura T
    Am Rev Respir Dis; 1989 Dec; 140(6):1595-601. PubMed ID: 2513762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pulmonary clearance of smooth and rough strains of Pseudomonas aeruginosa.
    Martin HG; Warren JR; Dunn MM
    Am Rev Respir Dis; 1989 Jul; 140(1):206-10. PubMed ID: 2502052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
    Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxin protection from oxygen toxicity: effect on pulmonary neutrophils and L-selectin.
    Keeney SE; Mathews MJ; Shattuck KE; Dallas DV
    Inflammation; 2002 Oct; 26(5):243-52. PubMed ID: 12238567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa clearance in mice: comparison of tissue, strain, and corticosteroid effects.
    Nugent KM; Cox CD; Pesanti EL
    Infect Immun; 1984 Mar; 43(3):901-5. PubMed ID: 6421740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated β
    Wilson ZS; Ahn LB; Serratelli WS; Belley MD; Lomas-Neira J; Sen M; Lefort CT
    Am J Respir Cell Mol Biol; 2017 May; 56(5):620-627. PubMed ID: 28157452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Myeloid Cell Production and Lung Bacterial Clearance in Mice Exposed to Cigarette Smoke.
    Basilico P; Cremona TP; Oevermann A; Piersigilli A; Benarafa C
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):424-35. PubMed ID: 26273827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?
    Trøstrup H; Lerche CJ; Christophersen LJ; Thomsen K; Jensen PØ; Hougen HP; Høiby N; Moser C
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28645160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa.
    Grassmé H; Kirschnek S; Riethmueller J; Riehle A; von Kürthy G; Lang F; Weller M; Gulbins E
    Science; 2000 Oct; 290(5491):527-30. PubMed ID: 11039936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
    Ding FM; Zhu SL; Shen C; Jiang YQ
    Respirology; 2012 May; 17(4):727-34. PubMed ID: 22404374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.